Daniel S. James

Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor

M. Raymond V. Finlay, Mark J. Anderton, Susan Ashton et al. · Journal of Medicinal Chemistry · 2014 · 590 citations · Full text

Genetics, Pathology, Clinical Candidate +18

Origins of Enantioselectivity with Nitrogen−Sulfur Chelate Ligands in Palladium-Catalyzed Allylic Substitution

Harry Adams, James C. Anderson, Rachel J. Cubbon et al. · The Journal of Organic Chemistry · 1999 · 56 citations

Cross-coupling Reaction, Engineering, Biochemistry +14

Naphthyl ketones: a new class of Janus kinase 3 inhibitors

George R. Brown, Andrea M. Bamford, Jonathan Bowyer et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 56 citations · Full text

Medicinal Chemistry, Medicine, Receptor Tyrosine Kinase +9

Concepts for ligand design in asymmetric catalysis: a study of chiral amino thiol ligands

James C. Anderson, Rachel J. Cubbon, Michael Harding et al. · Tetrahedron Asymmetry · 1998 · 54 citations

Engineering, Ligand Design, Organometallic Catalysis +6

Sulfur–imine mixed donor chelate ligands for asymmetric catalysis: enantioselective allylic alkylation

James C. Anderson, Daniel S. James, John P. Mathias · Tetrahedron Asymmetry · 1998 · 54 citations

Chemical Engineering, Engineering, Organic Chemistry +6